Broadway Wealth Solutions’s Thermo Fisher Scientific TMO Stock Holding History

Broadway Wealth Solutions’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Buy	751 +59	+9%	+$28.3K	0.18%	46
2026 Q1	$340K	Buy	692 +79	+13%	+$42.9K	0.18%	58
2025 Q4	$355K	Sell	613 -80	-12%	-$45.2K	0.19%	52
2025 Q3	$336K	Buy	693 +13	+2%	+$6.05K	0.19%	54
2025 Q2	$276K	Buy	680 +128	+23%	+$53.5K	0.17%	74
2025 Q1	$275K	Hold	552	–	–	0.2%	63
2024 Q4	$287K	Buy	+552	New	+$303K	0.22%	65

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Broadway Wealth Solutions's TMO Position: Q2 2026 in Review

Broadway Wealth Solutions increased its Thermo Fisher Scientific (TMO) stake by 8.5% in Q2 2026, buying an estimated $28.3K and bringing the position to 751 shares worth $377K. The position accounts for 0.18% of the portfolio, ranked #46.

Broadway Wealth Solutions first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Broadway Wealth Solutions held 751 shares of Thermo Fisher Scientific worth $377K as of Q2 2026.
Broadway Wealth Solutions bought 59 Thermo Fisher Scientific shares in Q2 2026, an estimated $28.3K.
Thermo Fisher Scientific made up 0.18% of Broadway Wealth Solutions's portfolio in Q2 2026, its #46 holding.
Broadway Wealth Solutions first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Broadway Wealth Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.